Delivery Order SPE2DB24D2101-SPE2DB25FKMRC
- Not listed
- The Defense Logistics Agency awarded a $24,139.06 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $4,353.44 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $11,572.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injectors, with an ultimate completion date of December 16, 2025. This non-set-aside award represents a single delivery order transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.03 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.10 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on November 6, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL units). This competitively awarded, firm fixed-price delivery order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $13,898.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors, with an ultimate completion date of December 19, 2025. This non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,613.98 on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of September 8, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on July 24, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a routine pharmaceutical procurement for military healthcare needs. The contract was competitively awarded without set-aside designation and specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors, with a ceiling value of $1,015.28. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of September 12, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMRCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,081.35 for Mounjaro 10 mg/0.5 ml pen injectors on July 23, 2025, with ultimate completion by July 24, 2025. This firm fixed-price, competitively awarded contract involves pharmaceutical delivery to support federal medical procurement needs. The contract is issued without set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems through its extensive portfolio of medical product deliveries. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support for military healthcare programs, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The arrangement allows AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contract structure supporting worldwide military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/23/25 |